The portfolio to be acquired consists of global NRT brand Nicotinell and local brands Nicabate, Habitrol and Thrive in markets outside of the United States.
Alfaiate will be part of the executive management team, and will be responsible for strengthening corporate strategic functions and enhancing global marketing efforts.